Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2026 / Volume: 73 Issue: 4

Impact of antibiotic-induced gut dysbiosis model on bone mineralization and biomechanical properties in post-weaning rats

Bayram Süzer(Bursa Uludağ University, Faculty of Veterinary Medicine, Department of Anatomy)0000-0002-2687-1221
İlker Arıcan(Bursa Uludağ University, Faculty of Veterinary Medicine, Department of Anatomy)0000-0001-6342-0094
Ezgi Yumuşak(Bursa Uludağ University University, Faculty of Veterinary Medicine, Department of Pathology)0000-0002-7773-3419
Ahmet Akkoç(Bursa Uludağ University University, Faculty of Veterinary Medicine, Department of Pathology)0000-0002-5090-7917
Murat Yalçın(Bursa Uludağ University, Faculty of Veterinary Medicine, Department of Physiology)0000-0002-5600-8162
Pages
—
Publication Date
2026-10-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results demonstrated that antibiotic-induced DYS significantly reduced tibial ultimate force and stiffness while increasing displacement, indicating impaired bone mechanical integrity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The gut microbiota plays a crucial role in regulating host metabolism and homeostasis through immune, endocrine, and metabolic pathways.
📊
Key Findings & Data:To induce experimental intestinal dysbiosis, rats in the DYS and FMT groups were administered a broad-spectrum antibiotic mixture for 14 days following an established protocol.
💡
Conclusion & Impact:The results demonstrated that antibiotic-induced DYS significantly reduced tibial ultimate force and stiffness while increasing displacement, indicating impaired bone mechanical integrity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bone biomechanics · Bone mineralization · Dysbiosis

Abstract

The gut microbiota plays a crucial role in regulating host metabolism and homeostasis through immune, endocrine, and metabolic pathways. This study investigated the impact of antibiotic-induced microbial disruption during the critical post-weaning period on bone biomechanical properties and mineral composition and evaluated whether fecal microbiota transplantation (FMT) could reverse these alterations in rats. Following weaning, Sprague Dawley rats were allocated to control (CON), dysbiosis (DYS), and FMT groups. To induce experimental intestinal dysbiosis, rats in the DYS and FMT groups were administered a broad-spectrum antibiotic mixture for 14 days following an established protocol. Subsequently, the FMT group received daily fecal suspensions from healthy donor rats for 10 days. At 8 weeks of age, tibial biomechanical integrity was assessed via three-point bending tests, and bone mineral composition was determined through crude ash, calcium (Ca), and phosphorus (P) analyses. The results demonstrated that antibiotic-induced DYS significantly reduced tibial ultimate force and stiffness while increasing displacement, indicating impaired bone mechanical integrity. In addition, DYS significantly decreased crude bone ash content as well as Ca and P levels. While histopathological examination did not reveal marked structural alterations among the groups, the FMT intervention partially restored bone mechanical strength and mineral composition toward control levels. These findings suggest that antibiotic-induced perturbations during early development negatively affect bone mineralization and biomechanics, while the partial recovery following FMT supports the concept of a functional gut–bone axis.

🔖

Cite This Article

Süzer, B., Arıcan, İ., Yumuşak, E., Akkoç, A., Yalçın, M. (2026). Impact of antibiotic-induced gut dysbiosis model on bone mineralization and biomechanical properties in post-weaning rats. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Volume: 73 Issue: 4. https://doi.org/10.33988/auvfd.1910833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (33)

  1. Allegretti JR, Hamilton MJ (2014): Restoring the gut microbiome for the treatment of inflammatory bowel diseases. World J Gastroenterol, 20, 3468–3474. DOI: 10.3748/wjg.v20.i13.3468.
  2. Chen R, Xu Y, Wu P, et al (2019): Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota. Pharmacol Res, 148, 104403. DOI:10.1016/j.phrs.2019. 104403.
  3. Chen YC, Greenbaum J, Shen H, et al (2017): Association between gut microbiota and bone health: Potential mechanisms and prospective. J Clin Endocrinol Metab, 102, 3635–3646. DOI:10.1210/jc.2017-00513.
  4. Collins FL, Rios-Arce ND, Schepper JD, et al (2017): The potential of probiotics as a therapy for osteoporosis. Microbiol Spectr, 5, 1-16. DOI:10.1128/microbiolspec. BAD-0015-2016.
  5. Han D, Wang W, Gong J, et al (2024): Microbiota metabolites in bone: Shaping health and confronting disease. Heliyon, 10, e28435. DOI:10.1016/j.heliyon.2024. e28435.
  6. Jha SS, Jeyaraman N, Jeyaraman M, et al (2025): Cross-talks between osteoporosis and gut microbiome. World J Orthop, 16, 102274. DOI: 10.5312/wjo.v16.i3.102274.
  7. Jian C, Carpén N, Helve O, et al (2021): Early-life gut microbiota and its connection to metabolic health in children: Perspective on ecological drivers and need for quantitative approach. EBioMedicine, 69, 103475. DOI: 10.1016/j.ebiom.2021.103475.
  8. Jiang X, Stockwell BR, Conrad M (2021): Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 22, 266–282. DOI: 10.1038/s41580-020-00324-8.
  9. Kho ZY, Lal SK (2018): The human gut microbiome – a potential controller of wellness and disease. Front Microbiol, 9, 1835. DOI: 10.3389/fmicb.2018.01835.
  10. Li R, Boer CG, Oei L, et al (2021): The gut microbiome: A new frontier in musculoskeletal research. Curr Osteoporos Rep, 19, 347–357. DOI: 10.1007/s11914-021-00675-x.
  11. Lucas S, Omata Y, Hofmann J, et al (2018): Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun, 9, 55. DOI: 10.1038/s41467-017-02490-4.
  12. Miyagawa K, Kozai Y, Ito Y, et al (2011): A novel underuse model shows that inactivity but not ovariectomy determines the deteriorated material properties and geometry of cortical bone in the tibia of adult rats. J Bone Miner Metab, 29, 422-436. DOI: 10.1007/s00774-010-0241-9.
  13. Ohlsson C, Sjögren K (2015): Effects of the gut microbiota on bone mass. Trends Endocrinol Metab, 26, 69–74. DOI: 10.1016/j.tem.2014.11.004.
  14. Onbaşılar İ, Yalçın S, Eser H, et al (2025): Combined use of essential oils with organic acids in modifying performance, intestinal health, caecal microflora, and selected blood and bone parameters in broilers. Ankara Univ Vet Fak Derg, 72, 377-386. DOI:10.33988/auvfd. 1613810.
  15. Principi N, Esposito S (2016): Antibiotic administration and the development of obesity in children. Int J Antimicrob Agents, 47, 171–177. DOI: 10.1016/j.ijantimicag.2015.12. 017.
  16. Quach D, Collins F, Parameswaran N, et al (2018): Microbiota reconstitution does not cause bone loss in germ-free mice. mSphere, 3, e00545-17. DOI:10.1128/ mspheredirect.00545-17.
  17. Sjögren K, Engdahl C, Henning P, et al (2012): The gut microbiota regulates bone mass in mice. J Bone Miner Res, 27, 1357–1367. DOI:10.1002/jbmr.1588.
  18. Tulstrup MV, Christensen EG, Carvalho V, et al (2015): Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class. PLoS One, 10, e0144854. DOI: 10.1371/journal.pone.0144854.
  19. Tulstrup MV, Roager HM, Thaarup IC, et al (2018): Antibiotic treatment of rat dams affects bacterial colonization and causes decreased weight gain in pups. Commun Biol, 1, 145. DOI: 10.1038/s42003-018-0140-5.
  20. Turnbaugh PJ, Ley RE, Hamady M, et al (2007): The human microbiome project. Nature, 449, 804–810. DOI:10.1038/nature06244.
  21. Tyagi AM, Darby TM, Hsu E, et al (2021): The gut microbiota is a transmissible determinant of skeletal maturation. eLife, 10, e64237. DOI:10.7554/eLife.64237.
  22. Vahidi G, Moody M, Welhaven HD, et al (2023): Germ-free C57BL/6 mice have increased bone mass and altered matrix properties but not decreased bone fracture resistance. J Bone Miner Res, 38, 1154–1174. DOI: 10.1002/jbmr.4835.
  23. Wallimann A, Magrath W, Thompson K, et al (2021): Gut microbial-derived short-chain fatty acids and bone: A potential role in fracture healing. Eur Cell Mater, 41, 454–470. DOI:10.22203/eCM.v041a29.
  24. Wang Y, Li Y, Bo L, et al (2023): Progress of linking gut microbiota and musculoskeletal health: causality, mechanisms, and translational values. Gut Microbes, 15, 2263207. DOI: 10.1080/19490976.2023.2263207.
  25. Wang Z, Yan Q, Wang Z, et al (2024): Ferroptosis and its implications in bone-related diseases. PeerJ, 12, e18626. DOI: 10.7717/peerj.18626.
  26. Wawrzyniak A, Balawender K (2022): Structural and metabolic changes in bone. Animals, 12, 1946. DOI: 10.3390/ani12151946.
  27. Whisner CM, Castillo LF (2018): Prebiotics, bone and mineral metabolism. Calcif Tissue Int, 102, 443–479. DOI: 10.1007/s00223-017-0339-3.
  28. Williams HR, Chin TE, Tokach MD, et al (2023): The effect of bone and analytical methods on the assessment of bone mineralization response to dietary phosphorus, phytase, and vitamin D in nursery pigs. J Anim Sci, 101, skad353. DOI: 10.1093/jas/skad353.
  29. Wilkins AT, Reimer RA (2021): Obesity, early life gut microbiota, and antibiotics. Microorganisms, 9, 413. DOI: 10.3390/microorganisms9020413.
  30. Wu J, Zhang S, Wu J, et al (2026): Targeting the gut-bone axis through exercise: A novel approach to osteoporosis prevention and treatment. Int J Mol Med, 57, 91. DOI: 10.3892/ijmm.2026.5762.
  31. Wu KC, McCauley KE, Lynch SV, et al (2024): Alteration in the gut microbiome is associated with changes in bone metabolism after laparoscopic sleeve gastrectomy. J Bone Miner Res, 39, 95–105. DOI: 10.1093/jbmr/zjad017.
  32. Xu P, Lin B, Deng X, et al (2022). VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2/GPX4 pathway in age-related osteoporosis. Free Radic Biol Med, 193, 720–735. DOI:10.1016/j.freeradbiomed.2022.11.013.
  33. Zaiss MM, Jones RM, Schett G, et al (2019): The gut-bone axis: how bacterial metabolites bridge the distance. J Clin Invest, 129, 3018–3028. DOI: 10.1172/JCI128521.